poisar

Stock

Traws Pharma, Inc. TRAW

$0.60+14.04%

Overview

TRAW market data

Price History

TRAW price chart · 1M
O
0.585000
H
0.604400
L
0.585000
C
0.604400
Vol
940.00
Source
US equities market feed
Observed
Aug 26, 2026, 12:00 AM
Cadence
Five-minute page cache; daily and stored hourly bars
Status
fresh

Key Stats & Performance

Open
$0.59
Previous Close
$0.53
Day High
$0.60
Day Low
$0.59
52 Week High
$3.23
52 Week Low
$0.45
7 Day Return
+9.89%
30 Day Return
+17.34%
90 Day Return
-61.01%
1 Year Return
-53.33%
Daily Notional Volume
$568.1
Latest daily bar volume multiplied by its closing price.

Valuation & Profitability

Provider-backed
P/E (TTM)
0.96
Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
Forward P/E
P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
EPS (TTM)
$1.09
Diluted earnings per share over the trailing twelve months.
Beta
1.53
Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
Dividend Yield
Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
Profit Margin
-616.8%
Net income divided by revenue. Comparable within a sector, less so across sectors.
52w range
$0.43 – $3.27
Lowest and highest closing prices over the past 52 weeks.
Analyst Target
Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.

Display-only. Refreshed once per symbol per 24 hours · market cap $8.8M · P/S 3.04.

Company News

10 captured
HC Wainwright & Co. Reiterates Neutral on Traws Pharma, Maintains $1 Price TargetBenzinga · Aug 18, 2026, 11:34 AM
Traws Pharma Q2 EPS $(0.16) Beats $(0.34) EstimateBenzinga · Aug 14, 2026, 8:56 PM
8-K filing — Traws Pharma, Inc. (TRAW)SEC EDGAR · Aug 14, 2026, 8:30 PM
WHO Director-General Ghebreyesus Says He Considers The Cruise Ship-Linked Hantavirus Outbreak To Be OverBenzinga · Jul 2, 2026, 1:25 PM
Traws PharmaFiles Prospectus For Mixed Shelf Offering Of Up To ~$139.2MBenzinga · Jul 1, 2026, 8:10 PM
Traws Pharma Announces That An Updated Toxicology Data Package Is Being Developed In Response To The UK MHRA's Information Requirements For Planned Testing Of Tivoxavir Marboxil In A Phase 2a Human Influenza Challenge StudyBenzinga · Jun 22, 2026, 11:15 AM
This Intuit Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For ThursdayBenzinga · Jun 18, 2026, 12:15 PM
HC Wainwright & Co. Downgrades Traws Pharma to Neutral, Announces $1 Price TargetBenzinga · Jun 18, 2026, 12:10 PM
Ladenburg Thalmann Downgrades Traws Pharma to NeutralBenzinga · Jun 15, 2026, 4:20 PM
Traws Pharma Stock Falls As UK Regulator Delays Key Flu StudyBenzinga · Jun 15, 2026, 3:15 PM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock